Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Lockdown benefit varies among countries and sub-national units: a reanalysis of the data by Bendavid et al. (2021)

View ORCID ProfileLukas Boesch
doi: https://doi.org/10.1101/2021.02.17.21251898
Lukas Boesch
University of Leipzig, Institute of Sociology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lukas Boesch
  • For correspondence: lukas.boesch@uni-leipzig.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Are the lockdown measures limiting the propagation of COVID-19? Recent analyses on the effectiveness of non-pharmaceutical interventions in reducing COVID-19 growth rates delivered conflicting conclusions. While Haug et al. (2020) did find strong empirical support for reductions in COVID-19 growth rates, Bendavid et al. (2021) did not. Here, I present the results of a reanalysis of the data by Bendavid et al. (2021). Instead of relying on pairwise comparisons between 10 countries with fixed-effects regression models to isolate the effect of lockdown measures, I modelled the development of the pandemic with and without lockdown measures for the entire period and all countries included in the data with one mixed-effects regression model. My results reconciled the conflicting conclusions of Haug et al. (2020) and Bendavid et al. (2021): while mandatory business closure orders did not affect COVID-19 growth rates, a general decrease in COVID-19 growth rates was attributable to the implementation of mandatory stay-at-home orders. However, the effect of mandatory stay-at-home orders varied, being weaker, even zero, in some countries and sub-national units and stronger in others, where COVID-19 growth rates only decreased due to the implementation of mandatory stay-at-home orders. The heterogeneity in the effect of mandatory stay-at-home orders on the spread of COVID-19 is challenging from a scientific and political point of view.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The university of Leipzig funded my research

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

I conducted a reanalysis of the data in Bendavid et al. (2021). No oversight body approved the research

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • I added two people to the acknowledgement and the .R files to recapitulate my analysis

Data Availability

Data is already available in Bendavid et al. (2021)

https://onlinelibrary.wiley.com/doi/10.1111/eci.13484

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted March 09, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Lockdown benefit varies among countries and sub-national units: a reanalysis of the data by Bendavid et al. (2021)
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Lockdown benefit varies among countries and sub-national units: a reanalysis of the data by Bendavid et al. (2021)
Lukas Boesch
medRxiv 2021.02.17.21251898; doi: https://doi.org/10.1101/2021.02.17.21251898
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Lockdown benefit varies among countries and sub-national units: a reanalysis of the data by Bendavid et al. (2021)
Lukas Boesch
medRxiv 2021.02.17.21251898; doi: https://doi.org/10.1101/2021.02.17.21251898

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Policy
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (525)
  • Anesthesia (125)
  • Cardiovascular Medicine (1434)
  • Dentistry and Oral Medicine (220)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (589)
  • Epidemiology (10330)
  • Forensic Medicine (6)
  • Gastroenterology (533)
  • Genetic and Genomic Medicine (2653)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1744)
  • Health Policy (791)
  • Health Systems and Quality Improvement (681)
  • Hematology (269)
  • HIV/AIDS (570)
  • Infectious Diseases (except HIV/AIDS) (12119)
  • Intensive Care and Critical Care Medicine (650)
  • Medical Education (276)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2483)
  • Nursing (145)
  • Nutrition (381)
  • Obstetrics and Gynecology (497)
  • Occupational and Environmental Health (569)
  • Oncology (1333)
  • Ophthalmology (403)
  • Orthopedics (152)
  • Otolaryngology (239)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (345)
  • Pediatrics (786)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (297)
  • Psychiatry and Clinical Psychology (2419)
  • Public and Global Health (5031)
  • Radiology and Imaging (901)
  • Rehabilitation Medicine and Physical Therapy (536)
  • Respiratory Medicine (688)
  • Rheumatology (309)
  • Sexual and Reproductive Health (257)
  • Sports Medicine (246)
  • Surgery (300)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)